Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.
Byrne J, Gu L, Garcia-Leon A, Gaillard CM, Saini G, Alalwan D, Tomás-Cortázar J, Kenny G, Donohue S, Reynolds B, O'Gorman T, Landay A, Doran P, Stemler J, Koehler P, Cox RJ, Olesen OF, Lelievre JD, O'Broin C, Savinelli S, Feeney ER, O'Halloran JA, Cotter A, Horgan M, Kelly C, Sadlier C, de Barra E, Cornely OA, Gautier V, Mallon PW.
Byrne J, et al.
Front Immunol. 2024 Sep 17;15:1445653. doi: 10.3389/fimmu.2024.1445653. eCollection 2024.
Front Immunol. 2024.
PMID: 39355249
Free PMC article.
INTRODUCTION: A clear immune correlate of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been defined. We explored antibody, B-cell, and T-cell responses to the third-dose vaccine and relationship to incident …
INTRODUCTION: A clear immune correlate of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …